Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity

Vaccine

Volumn 25, Issue 42, 2007, Pages 7301-7306

  Eyles, Jim E ^a   Butcher, Wendy A ^a   Titball, Richard W ^a   Hill, Jim ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Aerosol; Biodefense; Cholera toxin; Immunisation; Intradermal; Monoclonal antibodies; Pulmonary; Therapy; Vaccine

Indexed keywords

ALUMINUM HYDROXIDE; CHOLERA TOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7.3; MONOCLONAL ANTIBODY F1 04 A G1; PLAGUE VACCINE; RECOMBINANT PROTEIN F1; RECOMBINANT PROTEIN LCRV; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; YERSINIA PESTIS; YERSINIOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; CHOLERA TOXIN; EPITOPES, B-LYMPHOCYTE; FEMALE; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; TIME FACTORS; YERSINIA PESTIS;

EID: 34848869952     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.021     Document Type: Article

References (36)

1. Perry R.D., and Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10 1 (1997) 35-66
2. Andrews G.P., Heath D.G., Anderson G.W., Welkos S.L., and Friedlander A.M. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 64 6 (1996) 2180-2187
3. Heath D.G., Anderson G.W., Mauro J.M., Welkos S.L., Andrews G.P., Adamovicz J., et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16 11-12 (1998) 1131-1137
4. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active Immunisation with Recombinant V-Antigen from Yersinia-pestis protects mice against plague. Infect Immun 63 8 (1995) 2854-2858
5. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., and Titball R.W. A comparison of plague vaccine, Usp and Ev76 vaccine-induced protection against Yersinia-pestis in a murine model. Vaccine 13 16 (1995) 1551-1556
6. Titball R.W., and Williamson E.D. Yersinia pestis (plague) vaccines. Expert Opin Biol Ther 4 6 (2004) 965-973
7. Williamson E.D. Plague vaccine research and development. J Appl Microbiol 91 4 (2001) 606-608
8. Williamson E.D., and Titball R.W. Vaccines against dangerous pathogens. Brit Med Bull 62 (2002) 163-173
9. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 19 4-5 (2000) 566-571
10. Guiyoule A., Rasoamanana B., Buchrieser C., Michel P., Chanteau S., and Carniel E. Recent emergence of new variants of Yersinia pestis in Madagascar. J Clin Microbiol 35 11 (1997) 2826-2833
11. Guiyoule A., Gerbaud G., Buchrieser C., Galimand M., Rahalison L., Chanteau S., et al. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg Infect Dis 7 1 (2001) 43-48
12. Green M., Rogers D., Russell P., Stagg A.J., Bell D.L., Eley S.M., et al. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. Fems Immunol Med Microbiol 23 2 (1999) 107-113
13. Hill J., Leary S.E.C., Griffin K.F., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunisation. Infect Immun 65 11 (1997) 4476-4482
14. Motin V.L., Nakajima R., Smirnov G.B., and Brubaker R.R. Passive-immunity to Yersiniae mediated by anti-recombinant V-antigen and protein a-V-antigen fusion peptide. Infect Immun 62 10 (1994) 4192-4201
15. Hill J., Copse C., Leary S., Stagg A.J., Williamson E.D., and Titball R.W. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infect Immun 71 4 (2003) 2234-2238
16. Hill J., Eyles J.E., Elvin S.J., Healey G.D., Lukaszewski R.A., and Titball R.W. Administration of antibody to the lung protects mice against pneumonic plague. Infect Immun 74 5 (2006) 3068-3070
17. Carr S., Miller J., Leary S.E.C., Bennett A.M., Ho A., and Williamson E.D. Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems. Vaccine 18 1-2 (1999) 153-159
18. Titball R.W., Howells A.M., Oyston P.C.F., and Williamson E.D. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect Immun 65 5 (1997) 1926-1930
19. Anderson G.W., Worsham P.L., Bolt C.R., Andrews G.P., Welkos S.L., Friedlander A.M., et al. Protection of mice from fatal bubonic and pneumonic plague by passive immunisation with monoclonal antibodies against the F1 protein of Yersinia pestis. Am J Trop Med Hyg 56 4 (1997) 471-473
20. Sabhnani L., and Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. Fems Immunol Med Microbiol 27 2 (2000) 155-162
21. Eyles J.E., Elvin S.J., Westwood A., LeButt C.S., Alpar H.O., Somavarapu S., et al. Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine 22 31-32 (2004) 4365-4373
22. Bivas-Benita M., Zwier R., Junginger H.E., and Borchard G. Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur J Pharm Biopharm 61 3 (2005) 214-218
23. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague. Vaccine 15 10 (1997) 1079-1084
24. Eyles J.E., Sharp G.J.E., Williamson E.D., Spiers I.D., and Alpar H.O. Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine 16 7 (1998) 698-707
25. Russell P., Eley S.M., Bell D.L., Manchee R.J., and Titball R.W. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. J Antimicrob Chemother 37 4 (1996) 769-774
26. Zeitlin L., Cone R.A., Moench T.R., and Whaley K.J. Preventing infectious disease with passive immunisation. Microbes Infect 2 6 (2000) 701-708
27. Zeitlin L., Cone R.A., and Whaley K.J. Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. Emerg Infect Dis 5 1 (1999) 54-64
28. Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis 8 8 (2002) 833-841
29. Parent M.A., Berggren K.N., Kummer L.W., Wilhelm L.B., Szaba F.M., Mullarky I.K., et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 73 11 (2005) 7304-7310
30. Williamson E.D., Vesey P.M., Gillhespy K.J., Eley S.M., Green M., and Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 116 1 (1999) 107-114
31. vanBinnendijk R.S., Poelen M.C.M., vanAmerongen G., deVries P., and Osterhaus A. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 175 3 (1997) 524-532
32. Siegrist C.A., Barrios C., Martinez X., Brandt C., Berney M., Cordova M., et al. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur J Immunol 28 12 (1998) 4138-4148
33. Parent M.A., Berggren K.N., Mullarky I.K., Szaba F.M., Kummer L.W., Adamovicz J.J., et al. Yersinia pestis V protein epitopes recognized by CD4 T cells. Infect Immun 73 4 (2005) 2197-2204
34. Andrews G.P., Strachan S.T., Benner G.E., Sample A.K., Anderson G.W., Adamovicz J.J., et al. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun 67 3 (1999) 1533-1537
35. Matson J.S., Durick K.A., Bradley D.S., and Nilles M.L. Immunisation of mice with YscF provides protection from Yersinia pestis infections. Bmc Microbiol (2005) 5
36. Simonet M., Riot B., Fortineau N., and Berche P. Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infect Immun 64 1 (1996) 375-379